The objective of this study is to evaluate patient satisfaction in hepatitis C patients receiving PegIntron pen plus Rebetol. The rationale is that the effectiveness of treatment is correlated with adherence to the prescribed regimen which, in turn, is affected by the ease of use and accuracy of treatment administration. Since the PegIntron pen is a novel device, the results of this study will be used to improve the training of patients and healthcare providers in PegIntron pen use.
Study Type
OBSERVATIONAL
Enrollment
185
PegIntron pen administered in accordance with approved labeling
Rebetol administered in accordance with approved labeling.
Satisfaction of Patients Receiving PegIntron Pen Plus Rebetol Therapy, Assessed by a Survey.
The scale used in the patient questionnaire ranged from 0 (dissatisfied) to 8 (very satisfied). Patients evaluated the training received from the medical staff, ease of the preparation and administration of the medication, and the personal experience when using the PegIntron pen.
Time frame: The survey was administered during a follow-up visit in the clinic, at any point during the 48-week treatment.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.